查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529675

食物过敏诊断和治疗市场规模、份额和趋势分析报告：按产品、过敏原原材料、最终用途、地区、细分市场预测，2024-2030年

Food Allergy Diagnostics And Therapeutics Market Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Allergen Source, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

食物过敏诊断和治疗市场的成长和趋势：

根据Grand View Research, Inc.最新报告，预计到2030年，全球食物过敏诊断和治疗市场规模将达到132.8亿美元，预测期内复合年增长率为8.0%。

由于食物过敏的盛行率不断上升以及对管理这些疾病的产品的需求不断增长，预计未来几年该市场将成长。

PEG最大的应用是医疗，到2022年将占40%以上的市场占有率。 PEG 优异的混合性、吸湿性和无毒特性使其在锭剂和软膏等众多医药产品中具有很高的需求。不断增长的医药支出，尤其是印度、中国和巴西等新兴国家的医药支出，预计将在预测期内提振 PEG 市场。对油漆和涂料的需求不断增加，加上由于挥发性有机化合物排放低而越来越多地使用聚乙二醇作为溶剂，预计将在未来六年推动市场成长。

然而，在过敏反应的早期阶段使用自动注射器注射肾上腺素可以预防严重的併发症。美国每年花费约 250 亿美元治疗食物过敏。开发具有成本效益的体外诊断测试来检测过敏预计将推动对诊断产品的需求。

食物过敏诊断和治疗市场报告亮点

  • 由于抗组织胺和肾上腺素自动注射器的需求不断增加，治疗药物领域将在 2023 年占据市场主导地位。
  • 诊断细分市场包括设备、耗材和服务，耗材预计在预测期内将以最快的复合年增长率成长。
  • 最常用于诊断食物过敏的检查是皮肤点刺测试和血液检查。
  • 由于新产品的推出以及世界范围内花生过敏患病率的上升，预计花生过敏原成分领域将在预测期内出现良好的增长。
  • 由于严重过敏症状住院患者数量增加，2023年食物过敏诊断和治疗市场以医院和诊所为主。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章食物过敏诊断和治疗市场变数、趋势和范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 食物过敏诊断与治疗市场分析工具
    • 波特的分析
    • PESTEL分析

第四章食物过敏诊断和治疗市场：按产品估计和趋势分析

  • 细分仪表板
  • 食物过敏诊断与治疗市场：2023 年和 2030 年按产品分類的变化分析
  • 诊断
  • 治疗

第五章食物过敏诊断及治疗市场：依过敏原原料估算及趋势分析

  • 细分仪表板
  • 食物过敏诊断与治疗市场：2023 年和 2030 年过敏原来源分析
  • 花生
  • 牛奶
  • 蛋
  • 鱼
  • 贝类
  • 坚果
  • 小麦
  • 大豆
  • 其他的

第六章食物过敏诊断和治疗市场：最终用途的估计和趋势分析

  • 细分仪表板
  • 食物过敏诊断和治疗市场：2023 年和 2030 年最终用途的变化分析
  • 医院和诊所
  • 学术研究所
  • 诊断实验室

第七章食物过敏诊断和治疗市场：区域估计和趋势分析

  • 2023 年和 2030 年食物过敏诊断和治疗市场占有率（按地区）
  • 北美洲
    • 2018-2030年北美食物过敏诊断与治疗市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲食物过敏诊断与治疗市场估计与预测
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太地区食物过敏诊断与治疗市场估计与预测
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018-2030年拉丁美洲食物过敏诊断与治疗市场估计与预测
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 中东和非洲食物过敏诊断和治疗市场估计和预测，2018-2030
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Allergy Therapeutics
    • Cambridge Allergy Limited
    • Astellas Pharma, Inc
    • Immunomic Therapeutics, Inc
    • Prota Therapeutics Pty Ltd
    • Aimmune Therapeutics
    • Meridian Medical Technologies
    • ALK-Abello Ltd
    • Medeca Pharma AB
    • bioMerieux SA
    • Omega Diagnostics Group PLC
    • HYCOR Biomedical
    • HOB Biotech Group PLC
简介目录
Product Code: GVR-3-68038-746-9

Food Allergy Diagnostics And Therapeutics Market Growth & Trends:

The global food allergy diagnostics and therapeutics market size is expected to reach USD 13.28 billion by 2030, registering a CAGR of 8.0% during the forecast period, according to a new report by Grand View Research, Inc. The market is expected to grow in the coming years owing to increasing incidence of food allergies coupled with rising demand for products for management of these conditions.

Medical was the largest application for PEG, accounting for more than 40% of market share in 2022. Superior blending, hygroscopicity, and non-toxic properties of PEG have resulted in high demand for the chemical in numerous pharmaceutical products such as tablets and ointments. Increasing pharmaceutical expenditure, particularly in emerging economies of India, China, and Brazil, is expected to boost PEG market over the forecast period. Growing demand for paints & coatings coupled with the increasing use of PEG as a solvent due to its low VOC emissions is anticipated to fuel market growth over the next six years.

However, administering epinephrine using an auto-injector during the early stage of anaphylaxis might help avoid any serious complications. Treatment for food allergy costs around USD 25 billion annually in the U.S. Development of cost-effective in vitro diagnostic tests for detection of allergy is expected to fuel the demand for diagnostic products.

Food Allergy Diagnostics And Therapeutics Market Report Highlights:

  • Therapeutics segment dominated the market in 2023 due to growing demand for antihistamines and epinephrine auto-injector
  • Diagnostic segment includes instruments, consumables, and services, wherein consumables expected to grow at the fastest CAGR during the forecast period
  • The most common tests used to diagnose food allergies are skin prick tests and blood tests
  • Peanut allergen source segment is anticipated to register lucrative growth over the forecast period, owing to novel product launches coupled with rising incidence of peanut allergies worldwide.
  • Hospitals & clinics dominated the food allergy diagnostics & therapeutics market in 2023 owing to increase in number of hospitalizations due to severe allergic conditions

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Food Allergy Diagnostics and Therapeutics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Food Allergy Diagnostics and Therapeutics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Food Allergy Diagnostics and Therapeutics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Food Allergy Diagnostics and Theraoeutics Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Diagnostics
    • 4.3.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Therapeutics
    • 4.4.1. Therapeutics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Antihistamines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Epinephrine Auto-injector Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Food Allergy Diagnostics and Therapeutics Market: Allergen Source Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Food Allergy Diagnostics and Therapeutics Market: Allergen Source Analysis, 2023 & 2030 (USD Million)
  • 5.3. Peanuts
    • 5.3.1. Peanuts Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Milk
    • 5.4.1. Milk Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Eggs
    • 5.5.1. Eggs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Fish
    • 5.6.1. Fish Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Shellfish
    • 5.7.1. Shellfish Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Tree Nuts
    • 5.8.1. Tree Nuts Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Wheat
    • 5.9.1. Wheat Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Soy
    • 5.10.1. Soy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Food Allergy Diagnostics and Therapeutics Market: End use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Food Allergy Diagnostics and Therapeutics Market: End use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Hospitals and Clinics
    • 6.3.1. Hospitals And Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Academic Research Institutes
    • 6.4.1. Academic Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Diagnostics Laboratories
    • 6.5.1. Diagnostics Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Food Allergy Diagnostics and Therapeutics Market: Regional Estimates & Trend Analysis

  • 7.1. Food Allergy Diagnostics and Therapeutics Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.4. France
      • 7.3.4.1. France Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Spain
      • 7.3.5.1. Spain Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)
    • 7.3.6. Denmark
      • 7.3.6.1. Denmark Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)
    • 7.3.7. Sweden
      • 7.3.7.1. Sweden Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)
    • 7.3.8. Norway
      • 7.3.8.1. Norway Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1 Allergy Therapeutics
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Cambridge Allergy Limited
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Astellas Pharma, Inc
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Immunomic Therapeutics, Inc
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Prota Therapeutics Pty Ltd
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Aimmune Therapeutics
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Meridian Medical Technologies
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. ALK-Abello Ltd
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Medeca Pharma AB
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. bioMerieux SA
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives
    • 8.4.11. Omega Diagnostics Group PLC
      • 8.4.11.1. Participant's Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Recent Developments/ Strategic Initiatives
    • 8.4.12. HYCOR Biomedical
      • 8.4.12.1. Participant's Overview
      • 8.4.12.2. Financial Performance
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Recent Developments/ Strategic Initiatives
    • 8.4.13. HOB Biotech Group PLC
      • 8.4.13.1. Participant's Overview
      • 8.4.13.2. Financial Performance
      • 8.4.13.3. Product Benchmarking
      • 8.4.13.4. Recent Developments/ Strategic Initiatives